Analysed TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) News Sources
TransCode Therapeutics and Quantum Leap Announce Submission of IND Amendment for Phase 2a Clinical Trial with TTX-MC138
05-02-2026
yahoo.com
TransCode Therapeutics Announces Publication of Preclinical Testing of RIG-I Immunotherapeutic Candidate Supporting Further Development
23-02-2026
yahoo.com
TransCode Secures Exclusive, Worldwide, Fully Paid-Up Royalty-Free License to Develop and Commercialize a Next-Generation Oncolytic Immunotherapy Platform in an All-Stock Transaction Underscoring the Company's Dedication to Improving the Lives of Cancer Patients
03-03-2026
yahoo.com
CK Life Sciences Establishes Sequencio Therapeutics to Advance Therapeutic Cancer Vaccines Development
10-03-2026
yahoo.com
TransCode Therapeutics Enters into Agreements for up to $20 Million Flexible Financing, Extending Company's Runway into Late 2027/Early 2028
07-04-2026
yahoo.com
TransCode Therapeutics Appoints Dr. Anna Moore as Chair of Scientific Advisory Board; Announces Sponsored Research Agreement with Michigan State University
27-04-2026
yahoo.com
EXCLUSIVE: TransCode's RNA Therapeutic Achieves 64% Stable Disease Rate In Colorectal Cancer Phase 1 Study
03-06-2026
yahoo.com
TransCode Therapeutics Successfully Completes Phase 1a Clinical Trial, Reports Safety and Stabilization Data for TTX-MC138 in Metastatic Cancer
03-06-2026
yahoo.com
What is the current price of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?
The current price of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is $8.83.
TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) absolute price change since previous trading day?
The absolute price change of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) since the previous trading day is $-0.765.
TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) percentage price change since previous trading day?
The percentage price change of TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) since the previous trading day is -7.9729%.
What is the most recent average sentiment score for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?
The most recent average sentiment score for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)?
The most recent sentiment for TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ) is .
SEC-8K** Filing Available For TRANSCODE THERAPEUTICS INC (RNAZ:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.